Aortic endovascular repair
Clinical evidence
Strength in evidence
The proof is in the results.
You’re invested in durable outcomes for your patients. So are we. Medtronic maintains the longest-term aortic clinical evidence in the industry. We are invested in building the strength of aortic evidence that answers key clinical questions and elevates the standard of care.
Invested in building long-term clinical evidence
Medtronic maintains the longest-term clinical evidence in the industry, consistently showing successful clinical outcomes across different patient anatomies and the entire aortic portfolio.
- Unparalleled rigorous data collection process
- Medtronic ENGAGE OUS global patient registry with over 1,200 real-world participants and longest published evidence
- More than 400 peer-reviewed publications on the Valiant™ Captivia™ thoracic stent graft system
- Demonstrated outcomes through five years in all descending thoracic aorta (DTA) pathologies
- ANCHOR Registry five-year results on the Heli-FX™ EndoAnchor™ system
We are continuing to build our body of evidence by investing in randomized controlled trials (RCTs).
Endurant™ AAA stent graft system — the standard of EVAR durability with 10-year data
As the first and only EVAR (endovascular aortic repair) system with a decade of global registry outcomes, Endurant systems continue to prove durability and strength in evidence with with consistently high sac regression rates and low rate of aneurysm-related mortality (ARM).1
Choose the standard of EVAR durability.
Risks associated with EVAR procedures may include rupture, conversion to open repair, or secondary procedures.
Valiant™ Captivia™ thoracic stent graft system five-year outcomes in all DTA pathologies
The Valiant™ Captivia™ system provides consistent clinical performance across a variety of pathologies and five-year outcomes in all DTA pathologies.
Risks associated with TEVAR procedures may include rupture, conversion to open repair, or secondary procedures.
Proven durability with ESAR
EndoSuture aneurysm repair (ESAR) with the Heli-FX™ EndoAnchor™ system continues to demonstrate durable results in challenging patients with low type Ia endoleaks, low reinterventions, and positive sac regression rates.2
Risks with ESAR procedures may include failure to prevent/correct type I endoleaks, migration, or sac enlargement.